Susceptibility to atrial fibrillation: A study in an ovine model of pacing-induced early heart failure

Journal of Cardiovascular Electrophysiology

Volumn 9, Issue 4, 1998, Pages 423-435

  Power, John M ^a   Beacom, Graham A ^a   Alferness, Clif A ^b   Raman, Jai ^a   Wijffels, Maurits ^c   Farish, Stephen J ^a   Burrell, Louise M ^a   Tonkin, Andrew M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atrial dilatation; Atrial effective refractory period; Atrial vulnerability; Echocardiography; Electrophysiology

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE PACING; NONHUMAN; PRIORITY JOURNAL; SHEEP;

EID: 0031918020     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1998.tb00930.x     Document Type: Article

References (42)

1. Kopecky SL, Gersh BJ, McGoon MD, et al: The natural history of lone atrial fibrillation: A population based study over three decades. N Engl J Med 1987; 317:669-674.
2. Wijffels M, Kirchhof C, Dorland R, et al: Atrial fibrillation begets atrial fibrillation - A study in awake chronically instrumented goats. Circulation 1995;92: 1954-1968.
3. Kannel WB, Abbott RD, Savage DD, et al: Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-1022.
4. Dec G, Fuster V: Medical progress: Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564.
5. Jarvinen V, Kupari M, Poutanen V, et al: Right and left atrial phasic volumetric function in mildly symptomatic dilated and hypertrophic cardiomyopathy: Cine MR imaging assessment. Radiology 1996; 198:487-495.
6. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al: Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats. Circulation 1997; 96:3710-3720.
7. Wyndham C, Amat-y-Leon F, Wu D. et al: Effects of cycle length on atrial vulnerability. Circulation 1977; 55:260-267.
8. Friedman H, Sinha B, Tun A, et al: Zones of atrial vulnerability - Relationships to basic cycle length. Circulation 1996;94:1456-1464.
9. Centurion OA, Isomoto S, Shimizu A, et al: Supernormal atrial conduction and its relation to atrial vulnerability and atrial fibrillation in patients with sick sinus syndrome and paroxysmal atrial fibrillation. Am Heart J 1994;128:88-95.
10. Cosio F: Atrial vulnerability. Clin Cardiol 1992;15: 198-202.
11. Drago F, Turchetta A, Calzolari A, et al: Detection of atrial vulnerability by transesophageal atrial pacing and the relation of symptoms in children with Wolff-Parkinson-White syndrome and in a symptomatic control group. Am J Cardiol 1994;74:400-401.
12. Isomoto S, Shimizu A, Konoe A, et al: Effects of intravenous verapamil on atrial vulnerability. Jpn Circ J 1994;58:1-8.
13. Morillo CA, Klein GJ, Jones DL, et al: Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
14. Euler D, Scanlon P: Acetylcholine release by a stimulus train lowers atrial fibrillation threshold. Am J Physiol 1987;87:H863-H868.
15. Caplan LR, D'Cruz I, Hier DB, et al: Atrial size, atrial fibrillation, and stroke. Ann Neurol 1986;19:158-161.
16. Dittrich HC, Erickson JS, Schneiderman T, et al: Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989;63:193-197.
17. Armstrong PW, Moe GW, Howard RJ, et al: Structural remodelling in heart failure: Gelatinase induction. Can J Cardiol 1994;10:214-220.
18. Fitzpatrick M, Nichols M, Espiner E, et al: Neurohumoral changes during the onset and offset of ovine heart failure: Role of ANP. Am J Physiol 1989;256 (Heart Circ Physiol 25):H1052-H1059.
19. Moe GW, Grima EA, Howard RJ, et al: Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure. Cardiovasc Res 1994; 28:66-71.
20. Moe GW, Montgomery C, Howard RJ, et al: Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: Further insights into the mechanisms of canine experimental pacing-induced heart failure. J Lab Clin Med 1993;121:294-301.
21. Redfield MM, Aarhus LL, Wright RS, et al: Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation 1993; 87:2016-2022.
22. Ayers GM, Alferness CA, Ilina M, et al: Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994;89:413-422.
23. Cooper RA, Alferness CA, Smith WM, et al: Internal cardioversion of atrial fibrillation in sheep. Circulation 1993;87:1673-1686.
24. Powell AC, Garan H, McGovern BA, et al: Low energy conversion of atrial fibrillation in the sheep. J Am Coll Cardiol 1992;20:707-711.
25. Leistad E, Christensen G, Ilebekk A: Significance of increased atrial pressure on stroke volume during atrial fibrillation in anaesthetized pigs. Acta Physiol Scand 1993;149:157-161.
26. Keren G, Etzion T, Sherez J, et al: Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Am Heart J 1987;114:1146-1155.
27. Vaziri SM, Larson MG, Benjamin EJ, et al: Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994; 89:724-730.
28. Reimold SC, Lamas GA, Cantillon CO, et al: Risk factors for the development of recurrent atrial fibrillation: Role of pacing and clinical variables. Am Heart J 1995;129:1127-1132.
29. Andersen J, Egeblad H, Abildgaard U, et al: Atrial fibrillation and left atrial enlargement: Cause or effect? J Intern Med 1991;229:253-256.
30. Gosselink AT, Crijns HJ, Hamer HP, et al: Changes in left and right atrial size after cardioversion of atrial fibrillation: Role of mitral valve disease. J Am Coll Cardiol 1993;22:1666-1672.
31. Sanfilippo AJ, Abascal VM, Sheehan M, et al: Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990; 82:792-797.
32. Van Gelder IC, Crijns HJ, Van Gilst WH, et al: Decrease of right and left atrial sizes after direct-current electrical cardioversion in chronic atrial fibrillation. Am J Cardiol 1991;67:93-95.
33. Villecco AS, Pilati G, Bianchi G, et al: Left atrial size in paroxysmal atrial fibrillation: Echocardiographic evaluation and follow-up. Cardiology 1992;80:89-93.
34. Allessie M, Lammers WJEP, Bonke FI, et al: Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In Zipes D, Jalife J, eds: Cardiac Electrophysiology and Arrhythmias. Grune and Stratton, New York, 1985, pp. 265-275.
35. Allessie MA, Rensma PL, Brugada J, et al: Pathophysiology of atrial fibrillation. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders, Philadelphia, 1990, pp. 548-559.
36. Gondo N, Kumagai K, Matsuo K, et al: Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: Comparison with paroxysmal atrial fibrillation alone. Cardiology 1994;84:292-297.
37. Konoe A, Fukatani M, Tanigawa M, et al: Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation. PACE 1992; 15:1040-1052.
38. Kumagai K, Akimitsu S, Kawahira K, et al: Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991;84:1662-1668.
39. Kaseda S, Zipes DP: Contraction-excitation feedback in the atria: A cause of changes in refractoriness. J Am Coll Cardiol 1988;11:1327-1336.
40. Ravelli F, Allessie MA: Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997;96:1686-1695.
41. Sih HJ, Berbari EJ, Zipes DP: Epicardial maps of atrial fibrillation after linear ablation lesions. J Cardiovasc Electrophysiol 1997;8:1046-1054.
42. Spach M, Starmer C: Altering the topology of gap junctions - A major therapeutic target for atrial fibrillation. Cardiovasc Res 1995;30:336-344.